Pfizer Pays $14.5M To End Whistleblowers' FCA Suit
Pfizer Inc. agreed to pay $14.5 million to resolve claims brought by two ex-employee whistleblowers that it used kickbacks and deceptive marketing to convince Medicaid providers to prescribe a bladder control...To view the full article, register now.
Already a subscriber? Click here to view full article